NovoCure (NVCR) Depreciation and Depletion (2014 - 2015)

NovoCure's (NVCR) quarterly Depreciation and Depletion came in at -$657000.0 in Q4 2015, down 13.67% year-on-year from -$761014.0 in Q4 2014, and down 13.67% quarter-over-quarter from -$578000.0 in Q4 2014.

NovoCure (NVCR) Depreciation and Depletion (2014 - 2015) Analysis & Trends

NovoCure has disclosed Depreciation and Depletion across 2 years of filings, most recently posting -$657000.0 for Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 381.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 120.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 78.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 NovoCure 1.63 Bn 1.20 Bn 135.13 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 -657,000.00
Dec 31, 2015 -657,000.00
Dec 31, 2014 -578,000.00
Dec 31, 2014 -578,000.00